Changes in DNA result in the abnormal cell growth that causes cancer. Understanding these changes is driving the development of treatments to target the cancer's weaknesses.
Comprehensive biomarker testing helps identify changes in DNA and certain proteins. Their identification can guide oncologists in the selection of the most effective therapies for their patients. For certain types of cancer such as lung cancer, ovarian cancer, melanoma, there are already targeted drugs available. The field is moving quickly and there are new drugs on the horizon for breast cancer, bladder cancer and biliary tract cancer.
Join the Molecular Diagnostic Innovation Partnership to receive more educational materials on precision oncology: [ Ссылка ]
